Skip to content

Effect of Lower Extremity Traction on the Popliteal Angle After Percutaneous Needle Tenotomy of the Knee Flexor Muscles.

Effect of Lower Extremity Traction on the Popliteal Angle After Percutaneous Needle Tenotomy of the Knee Flexor Muscles.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05736328
Enrollment
20
Registered
2023-02-21
Start date
2023-03-02
Completion date
2024-02-28
Last updated
2023-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disability or Chronic Disease Leading to Disablement

Keywords

Neuro-Orthopaedics, Traction, Tenotomy, Disabled persons

Brief summary

People with neuromotor disability (i.e. following an inborn or acquired spinal cord, cerebral or peripheral neurological lesion) are at risk of neuro-orthopaedic disorders. Microinvasive percutaneous needle tenotomy is a frequent use alternative to open surgery to treat limb deformities. A lower extremity traction is performed in our unit during 2 to 7 days after surgery of the knee flexor muscles. The aim of this study is to describe the efficiency of lower extremity traction on the popliteal angle after percutaneous needle tenotomy of the knee flexor muscles.

Detailed description

This is a prospective, monocentric, cohort study of neurological disabled inpatients subjects treated in the perioperative disability unit (UPOH) of our university hospital for limb deformities by percutaneous needle tenotomy of the knee flexor muscles. All eligible inpatient subjects with neuromotor disability and admitted for the treatment of limb deformities by percutaneous needle tenotomy of the knee flexor muscles will be consecutively included. Data will be collected from the patients' medical records, in particular data related to their clinical, radiological, biological, and physiological examinations. This is a routine care study; no procedures are added for research purposes. It is an ancillary study to the NO-AGING study.

Interventions

PROCEDURETraction

Postoperative lower extremity traction

Sponsors

Assistance Publique - Hôpitaux de Paris
CollaboratorOTHER
Institut de Sante Parasport Connecte Synergies
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patients \>= 18 years old ; * Treated in the Perioperative Disability Unit (UPOH) of the Physical Medicine and Rehabilitation Department of our university hospital; * Admitted for the treatment of limb deformities by percutaneous needle tenotomy of the knee flexor muscles ; * Having a neuromotor disability; * No opposition to be enrolled in the study from the patient, or from a legally authorized close relative if the patient's state of health does not allow it; * Affiliation to a social security scheme.

Exclusion criteria

* Associated open surgery ; * Associated bone surgery ; * Under court protection.

Design outcomes

Primary

MeasureTime frameDescription
Popliteal angle at the end of the tractionDaily, during the traction (up to 7 days).Difference in popliteal angle between the beginning and end of traction, evaluated with the Kinovea angle measurement tool. In case of bilateral traction, the average of the differences of each limb will be considered.

Secondary

MeasureTime frameDescription
Success of surgeryAt 30 days after surgeryEvaluated by the Goal Assessment Scale (GAS). Minimum and maximum values : -2 (worse outcome) / +2 (better outcome)
Popliteal angleDaily, during the traction (up to 7 days).Evaluated by goniometry or Kinovea
Knee angleDaily, during the traction (up to 7 days).Evaluated by goniometry or Kinovea
PainDaily, during the traction (up to 7 days).Numeric scale or Algoplus according to disability. Minimum and maximum values for the Numeric scale : 0 (no pain) / 10 (worst pain). Minimum and maximum values for the Algoplus scale : 0 (no pain) / 5 (worst pain).
Skin conditionDaily, during the traction (up to 7 days).Presence of erythema, phlyctens or superficial pressure sores

Countries

France

Contacts

Primary ContactFrançois Genêt, MD-PhD
françois.genet@aphp.fr+ 33 1 47 10 70 82
Backup ContactVincent T. Carpentier, MD-MSc
vincent.carpentier@ispc-synergies.org+ 33 1 47 10 70 82

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026